Clinical Trials Browser

Esophageal Neoplasms × camrelizumab × 1 year × Clear all

NCT05176002 2025-11-19

Camrelizumab in Combination With Radiotherapy for Neoadjuvant Esophageal Carcinoma.

Phase 1/2 Active not recruiting

Gastrointestinal

Esophageal Neoplasms

NCT06869226 2025-10-02

A Multicenter Phase II Clinical Study of Neoadjuvant Use of Camrelizumab in Combination With Chemotherapy for Organ Preservation in Esophageal Cancer

Phase 2 Recruiting

Gastrointestinal

Esophageal Neoplasms